Copyright Reports & Markets. All rights reserved.

Global Meloxicam Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Meloxicam Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oral Preparations
    • 1.3.3 Topical Preparations
    • 1.3.4 Injections
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Meloxicam Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital Pharmacy
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Online Pharmacy
  • 1.5 Global Meloxicam Drugs Market Size & Forecast
    • 1.5.1 Global Meloxicam Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Meloxicam Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Meloxicam Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boehringer Ingelheim
    • 2.1.1 Boehringer Ingelheim Details
    • 2.1.2 Boehringer Ingelheim Major Business
    • 2.1.3 Boehringer Ingelheim Meloxicam Drugs Product and Services
    • 2.1.4 Boehringer Ingelheim Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.2 Iroko Pharmaceuticals
    • 2.2.1 Iroko Pharmaceuticals Details
    • 2.2.2 Iroko Pharmaceuticals Major Business
    • 2.2.3 Iroko Pharmaceuticals Meloxicam Drugs Product and Services
    • 2.2.4 Iroko Pharmaceuticals Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Iroko Pharmaceuticals Recent Developments/Updates
  • 2.3 Lupin
    • 2.3.1 Lupin Details
    • 2.3.2 Lupin Major Business
    • 2.3.3 Lupin Meloxicam Drugs Product and Services
    • 2.3.4 Lupin Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lupin Recent Developments/Updates
  • 2.4 Novitium Pharma
    • 2.4.1 Novitium Pharma Details
    • 2.4.2 Novitium Pharma Major Business
    • 2.4.3 Novitium Pharma Meloxicam Drugs Product and Services
    • 2.4.4 Novitium Pharma Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novitium Pharma Recent Developments/Updates
  • 2.5 Zydus
    • 2.5.1 Zydus Details
    • 2.5.2 Zydus Major Business
    • 2.5.3 Zydus Meloxicam Drugs Product and Services
    • 2.5.4 Zydus Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zydus Recent Developments/Updates
  • 2.6 Nipro
    • 2.6.1 Nipro Details
    • 2.6.2 Nipro Major Business
    • 2.6.3 Nipro Meloxicam Drugs Product and Services
    • 2.6.4 Nipro Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Nipro Recent Developments/Updates
  • 2.7 Luye Pharma
    • 2.7.1 Luye Pharma Details
    • 2.7.2 Luye Pharma Major Business
    • 2.7.3 Luye Pharma Meloxicam Drugs Product and Services
    • 2.7.4 Luye Pharma Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Luye Pharma Recent Developments/Updates
  • 2.8 Simcere Pharmaceutical
    • 2.8.1 Simcere Pharmaceutical Details
    • 2.8.2 Simcere Pharmaceutical Major Business
    • 2.8.3 Simcere Pharmaceutical Meloxicam Drugs Product and Services
    • 2.8.4 Simcere Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Simcere Pharmaceutical Recent Developments/Updates
  • 2.9 Kelun Pharmaceutical
    • 2.9.1 Kelun Pharmaceutical Details
    • 2.9.2 Kelun Pharmaceutical Major Business
    • 2.9.3 Kelun Pharmaceutical Meloxicam Drugs Product and Services
    • 2.9.4 Kelun Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Kelun Pharmaceutical Recent Developments/Updates
  • 2.10 YaoPharma
    • 2.10.1 YaoPharma Details
    • 2.10.2 YaoPharma Major Business
    • 2.10.3 YaoPharma Meloxicam Drugs Product and Services
    • 2.10.4 YaoPharma Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 YaoPharma Recent Developments/Updates
  • 2.11 Yangtze River Pharmaceutical
    • 2.11.1 Yangtze River Pharmaceutical Details
    • 2.11.2 Yangtze River Pharmaceutical Major Business
    • 2.11.3 Yangtze River Pharmaceutical Meloxicam Drugs Product and Services
    • 2.11.4 Yangtze River Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yangtze River Pharmaceutical Recent Developments/Updates
  • 2.12 Zhejiang Xianju Pharmaceutical
    • 2.12.1 Zhejiang Xianju Pharmaceutical Details
    • 2.12.2 Zhejiang Xianju Pharmaceutical Major Business
    • 2.12.3 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product and Services
    • 2.12.4 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
  • 2.13 Qilu Pharmaceutical
    • 2.13.1 Qilu Pharmaceutical Details
    • 2.13.2 Qilu Pharmaceutical Major Business
    • 2.13.3 Qilu Pharmaceutical Meloxicam Drugs Product and Services
    • 2.13.4 Qilu Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Qilu Pharmaceutical Recent Developments/Updates
  • 2.14 Jiangsu Jibeier Pharmaceutical
    • 2.14.1 Jiangsu Jibeier Pharmaceutical Details
    • 2.14.2 Jiangsu Jibeier Pharmaceutical Major Business
    • 2.14.3 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product and Services
    • 2.14.4 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Jiangsu Jibeier Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Meloxicam Drugs by Manufacturer

  • 3.1 Global Meloxicam Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Meloxicam Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Meloxicam Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Meloxicam Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Meloxicam Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Meloxicam Drugs Manufacturer Market Share in 2025
  • 3.5 Meloxicam Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Meloxicam Drugs Market: Region Footprint
    • 3.5.2 Meloxicam Drugs Market: Company Product Type Footprint
    • 3.5.3 Meloxicam Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Meloxicam Drugs Market Size by Region
    • 4.1.1 Global Meloxicam Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Meloxicam Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Meloxicam Drugs Average Price by Region (2021-2032)
  • 4.2 North America Meloxicam Drugs Consumption Value (2021-2032)
  • 4.3 Europe Meloxicam Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Meloxicam Drugs Consumption Value (2021-2032)
  • 4.5 South America Meloxicam Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Meloxicam Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Meloxicam Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Meloxicam Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Meloxicam Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Meloxicam Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Meloxicam Drugs Market Size by Country
    • 7.3.1 North America Meloxicam Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Meloxicam Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Meloxicam Drugs Market Size by Country
    • 8.3.1 Europe Meloxicam Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Meloxicam Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Meloxicam Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Meloxicam Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Meloxicam Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Meloxicam Drugs Market Size by Country
    • 10.3.1 South America Meloxicam Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Meloxicam Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Meloxicam Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Meloxicam Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Meloxicam Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Meloxicam Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Meloxicam Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Meloxicam Drugs Market Drivers
  • 12.2 Meloxicam Drugs Market Restraints
  • 12.3 Meloxicam Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Meloxicam Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Meloxicam Drugs
  • 13.3 Meloxicam Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Meloxicam Drugs Typical Distributors
  • 14.3 Meloxicam Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Meloxicam Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with conditions such as osteoarthritis and rheumatoid arthritis. It works by inhibiting the production of certain chemical messengers (prostaglandins) responsible for inflammation, pain, and fever.It is available in various forms, including tablets, capsules, and injections, and is typically prescribed for long-term management of chronic inflammatory conditions.
    This report is a detailed and comprehensive analysis for global Meloxicam Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Meloxicam Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Meloxicam Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Meloxicam Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Meloxicam Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Meloxicam Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Meloxicam Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Novitium Pharma, Zydus, Nipro, Luye Pharma, Simcere Pharmaceutical, Kelun Pharmaceutical, YaoPharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Meloxicam Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral Preparations
    Topical Preparations
    Injections
    Market segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy
    Major players covered
    Boehringer Ingelheim
    Iroko Pharmaceuticals
    Lupin
    Novitium Pharma
    Zydus
    Nipro
    Luye Pharma
    Simcere Pharmaceutical
    Kelun Pharmaceutical
    YaoPharma
    Yangtze River Pharmaceutical
    Zhejiang Xianju Pharmaceutical
    Qilu Pharmaceutical
    Jiangsu Jibeier Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Meloxicam Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Meloxicam Drugs, with price, sales quantity, revenue, and global market share of Meloxicam Drugs from 2021 to 2026.
    Chapter 3, the Meloxicam Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Meloxicam Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Meloxicam Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Meloxicam Drugs.
    Chapter 14 and 15, to describe Meloxicam Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now